Cargando…
The Increased Circulating Plasma Levels of Vascular Endothelial Growth Factor in Patients with Type 1 Diabetes Do Not Correlate to Metabolic Control
Aim. To characterize the plasma levels of vascular endothelial growth factor (VEGF) in type 1 diabetes mellitus (T1D) and its relation to both present and historical metabolic control and microvascular complications. Methods. Plasma levels of VEGF and routine clinical parameters were analyzed in 115...
Autores principales: | Singh, Kailash, Sandler, Stellan, Espes, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379085/ https://www.ncbi.nlm.nih.gov/pubmed/28421206 http://dx.doi.org/10.1155/2017/6192896 |
Ejemplares similares
-
Interleukin-35 administration counteracts established murine type 1 diabetes – possible involvement of regulatory T cells
por: Singh, Kailash, et al.
Publicado: (2015) -
Concomitant analysis of Helios and Neuropilin-1 as a marker to detect thymic derived regulatory T cells in naïve mice
por: Singh, Kailash, et al.
Publicado: (2015) -
Interleukin-35 Prevents Development of Autoimmune Diabetes Possibly by Maintaining the Phenotype of Regulatory B Cells
por: Luo, Zhengkang, et al.
Publicado: (2021) -
Plasma vascular endothelial but not fibroblast growth factor levels correlate with colorectal liver metastasis vascularity and volume
por: Davies, M M, et al.
Publicado: (2000) -
Association between SNPs of Circulating Vascular Endothelial Growth Factor Levels, Hypercholesterolemia and Metabolic Syndrome
por: Salami, Ali, et al.
Publicado: (2019)